Molecular Classification
Long non-coding RNA (lncRNA), Other
Other Names
CHROME, cholesterol homeostasis regulator of miRNA expression, PRKRA-AS1, PRKRA antisense RNA 1
Disease Roles
Cardiovascular diseaseAtherosclerosisLipid-related disease

Cholesterol induced regulator of metabolism RNA Overview

Cholesterol induced regulator of metabolism RNA (CHROMR, also known as CHROME or PRKRA-AS1) is a primate-specific long non-coding RNA located on human chromosome 2q31.2. CHROMR is upregulated in plasma and arterial plaques of patients with cardiovascular disease, and its expression is regulated by sterol-activated LXR transcription factors. Functionally, CHROMR promotes cholesterol efflux and HDL synthesis by inhibiting the activity of specific microRNAs (miR-27b, miR-33a/b, miR-128) that otherwise suppress ABCA1, an essential gene for HDL formation. Knockdown of CHROMR reduces cholesterol efflux and impairs nascent HDL biogenesis. CHROMR is being explored as a biomarker and experimental regulator for cholesterol-related diseases but is not a direct drug target, nor is it a receptor, enzyme, or transporter.

Mechanism of Action

Biological Functions

Regulation of cholesterol homeostasis
Regulation of microRNA activity
Cholesterol efflux
Regulation of HDL synthesis

Disease Associations

Cardiovascular disease
Atherosclerosis
Lipid-related disease
Other

Safety Considerations

  • Limited pharmacological tractability
  • Therapeutic targeting challenges due to poor conservation across species

Associated Biomarkers

Biomarker
Plasma CHROME/CHROMR levels (for cholesterol-related diseases, e.g. cardiovascular disease)